Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) — U.S “Medical Aesthetics Market – Focused Insights 2024-2029” reference has been added to ResearchAndMarkets.com offering.
The Medical Aesthetics Market was valued at USD 21.03 Billion in 2023 and is expected to reach USD 39.87 Billion by 2029, growing at a CAGR of 11.25%.
Global medical aesthetics market report contains exclusive data on 48 vendors. The market is highly competitive and dynamic, with numerous global, regional and local sellers. These vendors offer end users a variety of medical aesthetic procedure products, treatments and devices. Competition is intensifying from prominent international players such as AbbVie, Bausch Health Companies, Candela, Cutera, Cynosure, El.En. SpA, Galderma, Johnson & Johnson, Lumenis, Merz Pharma, Sientra, Sinclair and Sisram Medical.
It consistently influences market dynamics with its innovative solutions and advanced technologies. The leading market players are constantly introducing new aesthetic solutions with superior quality and technological features, contributing to market competitiveness. These companies also use strategic business moves such as partnerships, mergers and acquisitions of smaller and mid-sized market players.
The APAC region is expected to register the highest CAGR in the global medical aesthetics market during the projection period. The growth is mainly driven by the significant patient population and the increasing number of elderly people seeking cosmetic enhancements. Favorable demographic trends and increasing prevalence of conditions that can be treated through aesthetic treatments are driving the growth of the market. Enhanced access to medical aesthetic care and the continued expansion of such services across the region are further fueling this upward trend.
The rising costs of cosmetic procedures and the rapid acceptance of these treatments. This growth is particularly strong among the higher and middle income patient segments, who are increasingly adopting cosmetic procedures as part of their lifestyle changes. The dynamic nature of the market is evident in the varying levels of access to aesthetic treatments in different APAC countries. In emerging markets such as India and South Korea, the affordability of medical cosmetic procedures leads to high rates of treatment.
MARKET TRENDS & THE DRIVERS
Increasing demand for neurotoxins
The adoption of neurotoxins, particularly botulinum toxin (known as Botox), has seen a significant rise worldwide, transforming the landscape of medical aesthetics. This growth is driven by increasing demand for non-surgical, minimally invasive cosmetic procedures that deliver effective and fast results with minimal downtime. Neurotoxins are primarily used to reduce the appearance of fine lines and wrinkles by temporarily paralyzing the underlying muscles, leading to smoother, younger-looking skin. The popularity of these treatments has expanded beyond traditional cosmetic applications to include therapeutic uses, further expanding their appeal and market growth.
One of the major factors contributing to the increase in the adoption of neurotoxins is the growing awareness and acceptance of aesthetic procedures. Social media platforms, celebrity endorsements and the proliferation of beauty influencers have been instrumental in normalizing cosmetic enhancements. This has increased consumer interest and willingness to undergo such treatments, particularly among younger demographics looking for preventative anti-aging measures. The accessibility and affordability of neurotoxin treatments have also improved, making them more feasible for a wider audience. The therapeutic applications of neurotoxins have also contributed to their widespread adoption.
Increasing Advances in Medical Aesthetic Procedures
Advances in cosmetic medical procedures have revolutionized the field, offering improved efficacy, safety and patient satisfaction. The industry has seen significant innovation in surgical and non-surgical treatments, driven by technological advances, increased research and evolving patient expectations. These advances have broadened the scope of cosmetic procedures, making them more accessible and appealing to a wider range of people.
One of the most notable developments is in the area of non-surgical treatments. Minimally invasive procedures such as injectable neurotoxins (such as Botox) and dermal fillers have become incredibly popular due to their ability to provide quick, noticeable results with minimal downtime. The formulations of these injectables have been significantly improved, offering long-lasting results and more natural results. In addition, advanced techniques in the administration of these treatments have increased accuracy and safety, reducing the risk of side effects and complications. Laser and light treatments have also seen tremendous progress. Fractional lasers, intense pulsed light (IPL), and radiofrequency devices have become standard in the treatment of various skin conditions, including pigmentation, scarring, and wrinkles.
Increasing the Consumer Base for aesthetics
The growing consumer base for aesthetics is evidence of the growing demand for cosmetic procedures and treatments across various demographics. This expansion is driven by a number of factors, including social acceptance, technological advancements, improved accessibility, and shifting cultural perceptions of beauty and self-care. One of the major factors contributing to the growing consumer base is the widening social acceptance of cosmetic procedures.
Once considered a luxury for the wealthy or a taboo subject, cosmetic enhancements have gone mainstream. Influencers, celebrities and social media platforms have been instrumental in normalizing these processes by openly discussing their experiences and sharing the results. This visibility has reduced the stigma associated with cosmetic treatments, encouraging more people to consider and undergo such procedures. Technological advancements in medical aesthetics have also contributed significantly to the growing consumer base. Innovations in non-invasive and minimally invasive procedures such as laser treatments, injectables and body contouring technologies offer effective results with minimal downtime and reduced risk compared to traditional surgical methods.
INDUSTRY RESTRICTIONS
Side effects associated with medical aesthetic therapy
Post-procedural complications and customer complaints are major issues in aesthetic treatments despite technological advances and practices aimed at reducing risks. Complications can range from minor issues such as swelling, bruising or temporary discomfort to more serious complications such as infection, scarring or adverse reactions to treatment.
While cosmetic treatments can improve one’s appearance and self-confidence, they are not without risks. Physicians and patients must approach these procedures with care, transparency, and a commitment to safety to minimize complications and effectively address any customer complaints. This ongoing diligence and responsiveness is essential to maintaining trust and credibility in aesthetic medicine. To minimize complications and customer complaints, practitioners must undergo comprehensive training and stay up-to-date on the latest safety techniques and protocols.
Key Features:
| Attribute reference | Details |
| Number of pages | 180 |
| Prognostic period | 2023 – 2029 |
| Estimated market value (USD) in 2023 | $21.03 billion |
| Projected market value (USD) to 2029 | $39.87 billion |
| Compound Annual Growth Rate | 11.2% |
| Covered Areas | Catholic |
Key Sellers
- AbbVie
- Bausch Health Companies
- Candle
- Cutera
- Center of attention
- El.En. Spa
- Galderma
- Johnson & Johnson
- Lumenis
- Merz Pharma
- Sientra
- Sinclair
- Sisram medicine
Other prominent sellers
- Aerosol
- Aesthetic Biomedicine
- Asclepion Laser Technologies
- Astanza
- Beijing Sanhe Beauty S & T Co
- Beijing ADSS development
- Biolitec
- Biotec Italia
- BISON Medical
- Bluecore
- Brera Medical Technologies
- BTL Aesthetics
- Cards
- Dominion Aesthetic Technologies
- Erchonia
- CLOTHING
- Care Systems F
- Gigaalaser
- GSD
- InMode Aesthetic Solutions
- Leaflife technology
- LINLINE Medical Systems
- Lutronic
- Lynton laser
- MedArt ApS
- Microaire surgical instruments
- Medytox
- Meyer-Haake
- PhotoMedex
- Revance Aesthetics
- Sciton
- ThermiGen
- Concept of Venus
- Wavemed
- Zimmer MedizinSysteme
SEGMENT INSIGHT
Per product
- Injectables
- Energy-based devices
- Cosmetic Implants
- Cosmetics/Skin Care
By Process
- Non-invasive
- Minimally Invasive
By Gender
By Request
- Skin rejuvenation
- Body Contouring & Skin Tightening
- Breast augmentation
- Hair removal
- Others
By End User
- Hospitals & Dermatology Clinics
- Medical Spas & Aesthetic Centers
- Care at home
By Age Group
- Between 34-50 years old
- Over 50 Years
- Under 34 years old
For more information on this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.
